Shandong Luoxin Pharmacy Stock Co Ltd 8058 Financial And Strategic Analysis Review --- Aarkstore

Share:    

Shandong Luoxin Pharmacy Stock Co., Ltd

Shandong Luoxin Pharmacy Stock Co., Ltd. (8058) - Financial and Strategic Analysis Review

Shandong Luoxin Pharmacy Stock Co., Ltd. (Shandong Luoxin, formerly Shandong Luoxin Factory) is a pharmaceutical company engaged in the development, manufacture, and sale of pharmaceutical products. The company exclusively provides Chinese and Western medicine and bulk medicines. It offers quinolones, cephalosporins, -lactams, macrolides, tetracyclines, sulfonamides, anti-bacterials, anti-fungal drugs, digestive system medicines, circulatory system medicines, nervous system medicines, respiratory system medicines and many more. The company markets its products through a wide range of sales network across China.

Shandong Luoxin Pharmacy Stock Co., Ltd. Key Recent Developments

May 11, 2010: Shandong Luoxin Reports Net Profit Of RMB107 Million For Q1 2010

Mar 23, 2010: Luoxin Pharma Reports Increase In Turnover For 2009

This comprehensive SWOT profile of Shandong Luoxin Pharmacy Stock Co., Ltd. provides you an in-depth strategic analysis of the companys businesses and operations. The profile has been compiled to bring to you a clear and an unbiased view of the companys key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

This company report forms part of the Profile on Demand service, covering over 50,000 of the worlds leading companies. Once purchased, the highly qualified team of company analysts will comprehensively research and author a full financial and strategic analysis of Shandong Luoxin Pharmacy Stock Co., Ltd., including a detailed SWOT analysis, and deliver this direct to you in pdf format within two business days (excluding weekends).

The profile contains critical company information including*,

- Business description A detailed description of the companys operations and business divisions.

- Corporate strategy Analysts summarization of the companys business strategy.

- SWOT Analysis A detailed analysis of the companys strengths, weakness, opportunities and threats.

- Company history Progression of key events associated with the company.

- Major products and services A list of major products, services and brands of the company.

- Key competitors A list of key competitors to the company.

- Key employees A list of the key executives of the company.

- Executive biographies A brief summary of the executives employment history.

- Key operational heads A list of personnel heading key departments/functions.

- Important locations and subsidiaries A list and contact details of key locations and subsidiaries of the company.

- Key manufacturing facilities A list of key manufacturing facilities of the company.

- Detailed financial ratios for the past five years The latest financial ratios derived from the annual financial statements published by the company with 5 years history.

- Interim ratios for the last five interim periods The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

For more information please visit :

http://www.aarkstore.com/reports/Shandong-Luoxin-Pharmacy-Stock-Co-Ltd-8058-Financial-and-Strategic-Analysis-Review-51951.html

by: Aarkstore Enterprise

POST COMMENT

Shanghai Jiao Da Onlly Co., Ltd. (600530) - Financial And Strategic Analysis Review --- Aarkstore Aarkstore Enterprise-lifevantage Corporation (lfvn) - Financial And Strategic Analysis Review Beijing Tiantan Biological Products Co., Ltd. (600161) - Financial And Strategic Analysis Review Caplin Point Laboratories Ltd (524742) - Financial And Strategic Analysis Review --- Aarkstore Mediscience Planning Inc. (2182) - Financial And Strategic Analysis Review --- Aarkstore Enterprise Aarkstore Enterprise-lipidviro Tech, Inc. (lpvo) - Financial And Strategic Analysis Review Winteam Pharmaceutical Group Limited (570) - Financial And Strategic Analysis Review --- Aarkstore Southwest Synthetic Pharmaceutical Corporation Ltd. (788) - Financial And Strategic Analysis Review Zhejiang Hangzhou Xinfu Pharma Co Ltd 2019 Financial And Strategic Analysis Review --- Aarkstore Zhejiang Hisoar Pharmaceutical Co Ltd 2099 Financial And Strategic Analysis Review --- Aarkstore Aarkstore Enterprise-pt. Pyridam Farma Tbk. (pyfa) - Financial And Strategic Analysis Review Aarkstore Enterprise-sembiosys Genetics Inc. (sbs) - Financial And Strategic Analysis Review Aarkstore Enterprise-pharmesis International Ltd. (p31) - Financial And Strategic Analysis Review